Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06606 NH HEALTH

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders Naxin YAO & Associates (8.27%)
Yiyou CHEN & Family (7.98%)
Qiming Corporate GP V, Ltd. (7.84%)
Invesco Advisors, Inc. (7.01%)
Yeqing ZHU (6.15%)
Janus Henderson Group PLC (5.10%)
Sector Health Care & Biotechnology
Web Site https://ir.newhorizonbio.com Tel (86 571) 8110-7210
Email IR@nhbio.com.cn Fax (86 571) 8643-0935
Related Equities N/A
Principal Activities Principally engaged in research and development of screening products for colorectal cancer, cervical cancer and other types of cancer.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top